Neurobiological Technologies (Neurobiological Technologies) EV-to-FCF : 0.00 (As of Jun. 14, 2024)

Neurobiological Technologies EV-to-FCF Chart

Neurobiological Technologies Annual Data
	Trend	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09
EV-to-FCF		Get a 7-Day Free Trial					-7.31	7.76	-3.77	-0.47	0.34

Neurobiological Technologies Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Neurobiological Technologies's EV-to-FCF

For the Biotechnology subindustry, Neurobiological Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurobiological Technologies's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's EV-to-FCF falls into.

Neurobiological Technologies EV-to-FCF Calculation

Neurobiological Technologies's EV-to-FCF for today is calculated as:

Neurobiological Technologies's current Enterprise Value is $0.00 Mil.
Neurobiological Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies  (OTCPK:NTII) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Neurobiological Technologies's PE Ratio for today is calculated as:

Neurobiological Technologies's share price for today is $0.0001.
Neurobiological Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.420.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Neurobiological Technologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurobiological Technologies (Neurobiological Technologies) Business Description